Home > Riviste > Minerva Cardioangiologica > Fascicoli precedenti > Articles online first > Minerva Cardioangiologica 2018 Mar 15

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

MINERVA CARDIOANGIOLOGICA

Rivista sulle Malattie del Cuore e dei Vasi


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,695


eTOC

 

Minerva Cardioangiologica 2018 Mar 15

DOI: 10.23736/S0026-4725.18.04657-1

Copyright © 2018 EDIZIONI MINERVA MEDICA

lingua: Inglese

Transcatheter therapies for tricuspid regurgitation: coaptation augmentation devices

Edwin C. HO, Neil P. FAM

Division of Cardiology, St. Michael’s Hospital, Toronto, Canada


PDF  


Advancements in transcatheter technology has increased the number of therapeutic options for patients with tricuspid regurgitation. One category of repair devices attempts to augment leaflet coaptation by either leaflet plication or by functioning as a space occupying device. These include the MitraClip (Abbott, Santa Clara, CA, USA), PASCAL (Edwards Lifesciences, Irvine, CA, USA) and FORMA (Edwards Lifesciences, Irvine, CA, USA) devices. All three have been successfully implanted with promising short term echocardiographic and clinical outcomes. Improvements in patient selection, device design and procedural technique will lead to more effective tricuspid regurgitation reduction. Further research to assess efficacy, safety and durability of these devices is needed, along with determination of long-term clinical outcomes.


KEY WORDS: MitraClip - Tricuspid regurgitation - Transcatheter repair

inizio pagina

Publication History

Article first published online: March 15, 2018
Manuscript accepted: March 9, 2018
Manuscript received: March 2, 2018

Per citare questo articolo

Ho EC, Fam NP. Transcatheter therapies for tricuspid regurgitation: coaptation augmentation devices. Minerva Cardioangiol 2018 Mar 15. DOI: 10.23736/S0026-4725.18.04657-1

Corresponding author e-mail

famn@smh.ca